Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03792724
Title Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors (INTRUST)
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Clinica Universidad de Navarra, Universidad de Navarra


lung non-small cell carcinoma

kidney cancer

lung cancer

transitional cell carcinoma

urinary bladder cancer

colorectal cancer

Advanced Solid Tumor


Nivolumab + Urelumab

Age Groups: adult | senior
Covered Countries ESP

No variant requirements are available.